
| Date | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|
| 2026-04-28 | LEFKOFSKY ERIC P | Director & CEO and Chairman | Sale | 166.3K | $51.13 | $8.50M | 8.84M | View ↗ | |
| 2026-03-26 | LEFKOFSKY ERIC P | Director & CEO and Chairman | Sale | 166.3K | $46.38 | $7.71M | 8.88M | View ↗ | |
| 2026-03-02 | Epstein David R | Director | Sale | 250 | $50.69 | $13K | 25.8K | View ↗ | |
| 2026-03-02 | Rogers James William | Chief Financial Officer | Sale | 11.4K | $50.69 | $579K | 127.2K | View ↗ | |
| 2026-02-20 | Polovin Andrew | EVP, Chief Legal Officer | Sale | 10.9K | $60.31 | $660K | 126.9K | View ↗ |
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-01-14 | Nancy Pelosi(D-CA11) | house | Purchase | $50,001 - $100,000 |
No annual data found.
Is Tempus AI, Inc. (TEM) A Good Stock To Buy Now?
Tempus AI vs. Illumina: Which Oncology Stock Is Worth Buying Now?
Assessing Tempus AI (TEM) Valuation After A Recent Share Price Bounce
How The Tempus AI (TEM) Narrative Is Shifting Around Data, Partnerships And Growth Visibility